Ticker > Company >

EP Biocomposites share price

EP Biocomposites Ltd.

BSE: 543595 SECTOR: Plastic Products  26k   7   0

173.80
+24.75 (16.61%)
BSE: 05 Dec 4:00 PM

Price Summary

Today's High

₹ 174.4

Today's Low

₹ 156.5

52 Week High

₹ 218

52 Week Low

₹ 122

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

29.22 Cr.

Enterprise Value

29.76 Cr.

No. of Shares

0.17 Cr.

P/E

25.42

P/B

3.06

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  56.88

CASH

1.27 Cr.

DEBT

1.8 Cr.

Promoter Holding

70.08 %

EPS (TTM)

₹  6.84

Sales Growth

60.42%

ROE

12.79 %

ROCE

15.28%

Profit Growth

99.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year60.42%
3 Year57.14%
5 YearNA

Profit Growth

1 Year99.55%
3 Year47.53%
5 YearNA

ROE%

1 Year12.79%
3 Year30.58%
5 Year74.96%

ROCE %

1 Year15.28%
3 Year23.44%
5 Year86.65%

Debt/Equity

0.1884

Price to Cash Flow

-23.49

Interest Cover Ratio

42.0026

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 70.08 0.00
Jun 2024 70.08 0.00
Mar 2024 70.08 0.00
Dec 2023 70.08 0.00
Sep 2023 70.08 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 57.1407037993857% for the Past 3 years.
  • Company has been maintaining healthy ROE of 30.576986611598% over the past 3 years.
  • Company has been maintaining healthy ROCE of 23.4358200328407% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 42.0026.
  • Company’s PEG ratio is 0.255364959135232.
  • Company has a healthy liquidity position with current ratio of 2.8358.
  • The company has a high promoter holding of 70.08%.

 Limitations

  • Company has high debtor days of 237.0555.
  • Company has negative cash flow from operations of -1.2439.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0.57 2.95 8.06 7.13 11.44
Total Expenditure 0.52 2.49 6.65 6.15 10.03
Operating Profit 0.04 0.46 1.41 0.98 1.41
Other Income 0 0 0.02 0.17 0.3
Interest 0 0 0.19 0.23 0.04
Depreciation 0 0 0.07 0.1 0.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.04 0.46 1.17 0.81 1.57
Tax 0.01 0.11 0.36 0.24 0.42
Net Profit 0.03 0.36 0.81 0.58 1.15
Adjusted EPS (Rs.) 0.84 9.55 6.87 3.43 6.84

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.05 0.05 1.18 1.68 1.68
Total Reserves -0.02 0.34 0.82 6.73 7.88
Borrowings 0 0 2.18 1.2 1.1
Other N/C liabilities 0 0 0.14 0.03 -0.01
Current liabilities 0.52 0.94 4.96 2.08 4.41
Total Liabilities 0.55 1.32 9.28 11.72 15.07
Assets
Net Block 0 0 0.41 0.33 0.33
Capital WIP 0 0 0 0 0.14
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0.06 2.12 2.07
Other N/C Assets 0 0.02 0.23 0.01 0.03
Current Assets 0.55 1.3 8.58 9.26 12.49
Total Assets 0.55 1.32 9.28 11.72 15.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.04 0.46 1.17 0.81 1.57
Adjustment 0 0 0.22 0.26 0.06
Changes in Assets & Liabilities 0.07 -0.42 -5.5 -1.5 -2.47
Tax Paid 0 -0.01 -0.16 -0.36 -0.41
Operating Cash Flow 0.12 0.03 -4.28 -0.79 -1.24
Investing Cash Flow 0 0 -0.47 0.02 -0.16
Financing Cash Flow 0 0 4.76 2.81 0.49
Net Cash Flow 0.12 0.03 0.01 2.04 -0.92

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 70.08 70.08 70.08 70.08 70.08
ashma rajkumar kamat . - - - 0.31 0.31
leena rajkumar kamat . 64.93 - - 64.93 64.93
nimisha rajkumar kamat . 0.84 - - 0.84 0.84
rajkumar gajanan kamat . 3.99 - - 3.99 3.99
ashma rajkumar kamat 0.31 0.31 0.31 - -
leena rajkumar kamat - 64.93 64.93 - -
nimisha rajkumar kamat - 0.84 0.84 - -
rajkumar gajanan kamat - 3.99 3.99 - -
PARTICULARS Sep 2022% Mar 2023% Sep 2023% Dec 2023% Mar 2024%
investors 30.69 29.92 29.92 29.92 29.92
nav capital vcc - nav cap... 1.19 2.20 2.20 2.20 2.20
talib zafar - - 1.10 1.07 -
xtended business reportin... - 1.55 1.40 - -
mayuri shripal vora - 1.01 - - -
talib zafar 1.25 1.07 - - -
sanjay popatlal jain 2.97 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

EP Biocomposites Stock Price Analysis and Quick Research Report. Is EP Biocomposites an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

EP Biocomposites stock price today is Rs 173.8. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse EP Biocomposites . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). EP Biocomposites has a PE ratio of 25.4212497074655 which is high and comparatively overvalued .

  • Share Price: - The current share price of EP Biocomposites is Rs 173.8. One can use valuation calculators of ticker to know if EP Biocomposites share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. EP Biocomposites has ROA of 8.5828 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. EP Biocomposites has a Current ratio of 2.8358 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. EP Biocomposites has a ROE of 12.7887 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. EP Biocomposites has a Debt to Equity ratio of 0.1884 which means that the company has low proportion of debt in its capital.

  • Sales growth: - EP Biocomposites has reported revenue growth of 60.421 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of EP Biocomposites for the current financial year is 12.3320482896681 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for EP Biocomposites is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of EP Biocomposites is Rs 6.8368 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of EP Biocomposites in Ticker for free. Also, one can get the intrinsic value of EP Biocomposites by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about EP Biocomposites
X